2 Followers on Owler

Enterin

Read more
David McCullough's photo - CEO of Enterin

CEO

David McCullough

CEO Approval Rating

- -/100

Founded:

2015

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Enterin Acquisitions

No recent acquisitions found related to Enterin

Enterin Funding History

Since Enterin was founded in 2015, it has participated in 2 rounds of funding. In total Enterin has raised $29.4M. Enterin's last funding round was on Jan 2019 for a total of $16.7M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Jan 2019
$16.7M

New Ventures

Series A
Jul 2017
$12.7M

New Ventures III

Since Enterin was founded in 2015, it has participated in 2 rounds of funding. In total Enterin has raised $29.4M. Enterin's last funding round was on Jan 2019 for a total of $16.7M

Enterin Investments

No recent investments found related to Enterin

Enterin News

February 1, 2019The Business Journals: Philadelphia

Philadelphia biopharm firm targeting Parkinson's raises $16.7M

Enterin Inc. is following a different path for treating the neurological disorder.... See more »
July 26, 2017The Business Journals: Philadelphia

Philadelphia biotech firm take on Parkinson's with new approach

The company raised $12.7M in a series A financing.... See more »
July 17, 2017FierceBiotechIT

Backers put $12.7M behind Enterin's Parkinson's disease approach

Philadelphia biotech Enterin has raised $12.7 million in funding to pursue its hypothesis that the or... See more »
July 17, 2017FinSMEs

Enterin Completes $12.7M Series A Financing

Enterin, Inc., a Philadelphia, PA-based...... See more »

Enterin Press Releases

April 17, 2020StreetInsider

Enterin to Conduct a Randomized Phase 1/2a Study in Hospitalized Patients With COVID-19

PHILADELPHIA, April 17, 2020 /PRNewswire/ --Â ...... See more »
September 10, 2019ePRNews

ENT-01, Currently in Human Trials, Rejuvenates Aging Nervous System

Enterin Inc., a privately held, CNS-focused pharmaceutical company based in Philadelphia and developi... See more »
August 27, 2019ePRNews

Enterin's RASMET Study Published

Enterin Inc., a privately held, CNS-focused pharmaceutical company based in Philadelphia developing n... See more »
January 9, 2019StreetInsider

KARMET Study Begins Enrollment

PHILADELPHIA, Jan. 9, 2019 /PRNewswire/ -- Enterin Inc., a privately held CNS-focused pharmaceutical ... See more »
March 27, 2018ForImmediateRelease

Enterin's Phase 2a RASMET Study in Patients With Parkinson's Disease Completes Enrollment

Travel & Tourism Industry release: PHILADELPHIA, March 26, 2018 /PRNewswire/ - Enterin Inc., a CNS ph... See more »

Social Media

Enterin Headquarters

3624 Market St Ste 517 Suite 517

Philadelphia, Pennsylvania19104

Driving Directions »

Trending Companies

Enterin Summary

ABOUT

Overview

Enterin is engaged in the development of novel compounds for the treatment of Parkinson's disease. Enterin was founded in 2015. Enterin's headquarters is located in Philadelphia, Pennsylvania, USA 19104. It has raised 29.4M in 2 rounds. The latest rou...

Frequently Asked Questions about Enterin

  1. When was Enterin founded?

    Enterin was founded in 2015
  2. Who is Enterin's CEO?

    Enterin's CEO is David McCullough
  3. How much revenue does Enterin generate?

    Enterin generates $ < 1M in revenue
  1. How much funding does Enterin have?

    Enterin has historically raised $29.4M in funding
  2. Where is Enterin's headquarters?

    Enterin's headquarters is in Philadelphia Pennsylvania, USA
  3. How many employees does Enterin have?

    Enterin has 0 employees